Press Releases Archive

Magnolia Medical Awarded Innovative Technology Supplier of the Year by Vizient Inc.   Steripath® technology solution delivers exceptional clinical and economic impact for Vizient member hospitals – Seattle, WA -...

Magnolia Medical Appoints Former Becton Dickinson Senior Executives to Its Medical & Scientific Advisory Board  New expertise focused on advanced diagnostic technologies to improve sepsis testing accuracy – Seattle, WA - September...

Magnolia Medical Launches Mission to ZERO™ Aimed at Resetting the National Blood Culture Contamination Benchmark New initiative addresses hospitals' no. 1 concern1, while helping the more than 1.4 million patients...

Magnolia Medical Awarded Agreement with Intalere for Steripath Gen2 Initial Specimen Diversion Device Intalere hospital members benefit from the only FDA 510(k)-cleared device indicated to reduce blood culture contamination –...

Magnolia Medical Prevails in Summary Judgement for Baseless Lawsuit Filed by Kurin Inc. Magnolia continues to advance its unilateral multi-patent infringement lawsuit against Kurin – Seattle, WA, July 23, 2020...

Magnolia Medical Launches New Steripath Gen2 with Integrated Syringe First FDA-cleared blood culture diversion device with preassembled integrated syringe optimized for 'hard stick' patients and syringe collection protocols. – [...

Horizon Technology Finance Provides $20 Million Venture Loan Facility to Magnolia Medical Technologies – FARMINGTON, Conn., May 26, 2020 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that...

Newsweek Selects Steripath as a Best Infection Prevention Product of 2020 Newsweek's Best Health Care series highlights the nation's most promising products and technologies to help patients and the health...

Magnolia Medical Receives FDA 510K Clearance for Expanded Steripath Gen2 Product Family Products become the first and only indicated to reduce blood culture contamination   [ Seattle, WA - March...

Magnolia Medical Partners with Hospitals to Mitigate Critical Constraints Driven by COVID-19 Reducing false positive sepsis tests creates capacity for critical PCR lab equipment and increases bed availability – [...

Magnolia Medical Announces Partnership with Cardinal Health Improving patient care and reducing hospital costs with innovative Steripath Gen2 Device   [ Seattle, WA / Nov. 14, 2019 ] – Magnolia Medical Technologies...

12-month initiative demonstrates improved patient care and decreased hospital costs by reducing blood culture contamination – Seattle, WA (Oct. 2, 2019) – An Inova Fairfax initiative measuring the impact of the...

Magnolia Medical Technologies and The Center for Phlebotomy Education announced the expansion of their training and education partnership dedicated to the prevention of blood culture contamination.

(Seattle – April 17, 2019) – In the latest peer-reviewed published study on the impact of decreasing blood culture contamination rates using Steripath® ISDD®, researchers at Massachusetts General Hospital, Harvard...

New Evidence-Based Education Course Focuses on Best Practices to Prevent Blood Culture Contamination   Magnolia Medical Technologies, Inc. and The Center for Phlebotomy Education announced a collaborative training and education...

Magnolia Medical Receives Innovative Technology Contract from Vizient, Inc. for Steripath Gen2 Initial Specimen Diversion Device Magnolia Medical Technologies, Inc. announced today that it has been awarded an Innovative Technology...